Cord blood leptin levels in relation to child growth trajectories

Polyxeni Karakosta1, Theano Roumeliotaki2, Georgia Chalkiadaki2

  • 1Department of Social Medicine, School of Medicine, University of Crete, Heraklion, Greece; Department of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, Greece.

Insights

Cord blood leptin may influence childhood obesity development. Higher cord leptin levels are linked to lower childhood weight, especially in infants with specific growth patterns.

Area of Science:

  • Pediatric Endocrinology
  • Developmental Programming
  • Obesity Research

Background:

  • Leptin, a hormone regulating appetite and metabolism, is implicated in developmental programming.
  • Childhood obesity is a growing public health concern with complex origins.
  • Understanding early life factors like cord blood leptin is crucial for prevention.

Purpose of the Study:

  • To investigate the association between cord blood leptin levels and growth trajectories from birth to early childhood.
  • To determine if cord blood leptin influences the risk of childhood obesity.
  • To explore potential effect modification by intrauterine and early infancy growth patterns.

Main Methods:

  • Prospective cohort study (Rhea cohort, Crete, Greece) with 578 children followed to age 4.
  • Measurement of cord blood leptin and anthropometric/biometric data in early childhood.
  • Analysis using random-effects linear-spline and multivariable regression models.

Main Results:

  • Higher cord blood leptin was associated with lower weight, height, and BMI from 6 months to age 4.
  • Each SD increase in cord leptin correlated with a 242g lower weight at age 4.
  • This association was reversed in infants born small for gestational age or exhibiting rapid early growth.

Conclusions:

  • In utero leptin exposure has long-term programming effects extending into early childhood.
  • Early growth patterns may modify the impact of cord blood leptin on child development.
  • Further research is needed to elucidate these complex interactions.
Abstract

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.3K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
730
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.7K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.9K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
441
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.7K